BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35169717)

  • 1. Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse model.
    Sheriff L; Bending D
    STAR Protoc; 2022 Mar; 3(1):101161. PubMed ID: 35169717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of dual
    Jennings EK; Lecky DAJ; Ono M; Bending D
    STAR Protoc; 2021 Mar; 2(1):100284. PubMed ID: 33532733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing CD4 T cell differentiation in mouse small intestine using T cell transfer, lamina propria preparation, and flow cytometry.
    Duan J; Sun Y; Matute JD; Blumberg RS
    STAR Protoc; 2023 Sep; 4(3):102485. PubMed ID: 37566548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of T cells in mouse lymphoid tissue and blood with flow cytometry.
    Skordos I; Demeyer A; Beyaert R
    STAR Protoc; 2021 Mar; 2(1):100351. PubMed ID: 33665631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimized protocol for the retroviral transduction of mouse CD4 T cells.
    Eremenko E; Taylor ZV; Khand B; Zaccai S; Porgador A; Monsonego A
    STAR Protoc; 2021 Sep; 2(3):100719. PubMed ID: 34401785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol to isolate and enrich mouse splenic naive CD4
    Harada Y; Miyamoto K; Sujino T
    STAR Protoc; 2022 Dec; 3(4):101728. PubMed ID: 36170110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CyTOF mass cytometry analysis of human memory CD4
    Ioannidis LJ; Mitchell AJ; Zheng T; Hansen DS
    STAR Protoc; 2022 Jun; 3(2):101269. PubMed ID: 35378884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for the isolation of mouse senescence-associated CD4
    Fukushima Y; Minato N; Hattori M
    STAR Protoc; 2023 Sep; 4(3):102472. PubMed ID: 37515759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary culture of immature, naïve mouse CD4
    Wang W; Ai X
    STAR Protoc; 2021 Sep; 2(3):100756. PubMed ID: 34430922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol to establish a lung adenocarcinoma immunotherapy allograft mouse model with FACS and immunofluorescence-based analysis of tumor response.
    Peng Z; Yu M; Lin J; Dong T; Zhang X; Shi M; Qin M; Li S; Guo W; Zhang H; Sun S
    STAR Protoc; 2021 Jun; 2(2):100595. PubMed ID: 34169289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models.
    Effern M; Glodde N; Bawden E; Liebing J; Hinze D; Tüting T; Gebhardt T; Hölzel M
    STAR Protoc; 2022 Mar; 3(1):101038. PubMed ID: 35059651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models.
    Blanchard L; Vina E; Asrir A; Tardiveau C; Coudert J; Laffont R; Tarroux D; Bettini S; Veerman K; Lafouresse F; Pichery M; Mirey E; Bellard E; Ortega N; Girard JP
    STAR Protoc; 2022 Jun; 3(2):101444. PubMed ID: 35677615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and analyses of lamina propria lymphocytes from mouse intestines.
    Kim E; Tran M; Sun Y; Huh JR
    STAR Protoc; 2022 Jun; 3(2):101366. PubMed ID: 35573483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flow cytometry-based assay to investigate HIV-1 expression in SMYD5 shRNA containing primary CD4
    Boehm D; Ott M
    STAR Protoc; 2023 Dec; 4(4):102694. PubMed ID: 37925635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
    Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment.
    Mastandrea I; Sher D; Magod P; Friedmann-Morvinski D
    STAR Protoc; 2022 Mar; 3(1):101106. PubMed ID: 35098162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric characterization of tissue-resident lymphocytes after murine liver and heart transplantation.
    Prosser A; Dart S; Larma-Cornwall I; Lucas M
    STAR Protoc; 2021 Dec; 2(4):100810. PubMed ID: 34568841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine brain tumor microenvironment immunophenotyping using mass cytometry.
    McClellan BL; Alghamri MS; Thalla R; Lowenstein PR; Castro MG
    STAR Protoc; 2022 Jun; 3(2):101357. PubMed ID: 35634359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.